Good afternoon and welcome to Markets Desk, your midday read on what's moving markets and the stories behind the numbers.
Eli Lilly is getting a major distribution boost after CVS announced it will cover Lilly's GLP-one medications, including the pill Foundayo and the injectable Zepbound. That agreement could open access for millions of Americans and represents a significant commercial inflection point for Lilly's obesity and diabetes franchise, which has been racing to close the coverage gap that's held back broader adoption.
Shifting to energy, a new analysis puts hard numbers on just how dramatically the shale revolution reshaped the American economy. Before hydraulic fracturing and horizontal drilling scaled up in the mid two thousands, the United States was a net importer of natural gas with plans to expand that dependence. The productivity gains that followed didn't just flip the trade balance — they suppressed domestic energy costs for households and industry alike for nearly two decades.
And in aerospace, Blue Origin suffered a serious setback after its New Glenn rocket exploded during testing. Founder Jeff Bezos called it a very rough day and said the root cause remains under investigation. The incident is a meaningful blow to the company's ambitions as it works to establish itself as a credible rival to SpaceX in the commercial launch market.
That's the tape. Markets Desk, signing off the floor.
